Evidence map›Paper›PMID 38001624›Full record

ArticleCancers2023

The Prognostic Role of Body Mass Index on Oncological Outcomes of Upper Tract Urothelial Carcinoma.

Kang Liu, Hongda Zhao, Chi-Fai Ng, Jeremy Yuen-Chun Teoh, Pilar Laguna, Paolo Gontero, Iliya Saltirov, Jean de la Rosette

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Kang LiuS.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong 999077, China.ORCID 0000-0001-7929-6534
Hongda ZhaoS.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong 999077, China.
Chi-Fai NgS.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong 999077, China.ORCID 0000-0002-1723-9646
Jeremy Yuen-Chun TeohS.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong 999077, China.ORCID 0000-0002-9361-2342
Pilar LagunaDepartment of Urology, Medipol Mega University Hospital, Istanbul Medipol University, 34000 Istanbul, Turkey.
Paolo GonteroDepartment of Urology, University of Turin, 10124 Turin, Italy.
Iliya SaltirovDepartment of Urology and Nephrology, Military Medical Academy, 1000 Sofia, Bulgaria.ORCID 0000-0003-1434-7227
Jean de la RosetteDepartment of Urology, Medipol Mega University Hospital, Istanbul Medipol University, 34000 Istanbul, Turkey.ORCID 0000-0002-6308-1763
Chinese University of Hong Kong · HKIstanbul Medipol University · TRMilitary Medical Academy · BGUniversity of Turin · IT

Funding

Karl Storz (Germany) NA
6 · The paper itself

Abstract

(1) Objective: The aim of this study was to evaluate whether overweight and obese upper urinary tract carcinoma (UTUC) patients have better or worse survival outcomes. (2) Methods: The Clinical Research Office of the Endourology Society Urothelial Carcinomas of the Upper Tract (CROES-UTUC) Registry was used to extract the data of normal-weight or overweight/obese UTUC patients between 2014 and 2019. Patients with a BMI between 18.5 and 24.9 kg/m

Indexed as

body mass indexcancer-specific survivaloverall survivalrecurrence-free survivalupper tract urothelial carcinoma

Identifiers

PMID38001624
PMCPMC10670636
OpenAlexW4388557211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.